Over 12 months, Adicet Bio, Inc. saw more buying than selling from its insiders — purchases of about $1.6 million against sales of $675,000.
RA Capital Healthcare Fund LP (10% Owner) made the biggest buy, worth around $543,000.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. Big money check: 56 institutions held ACET as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | 74,577 | $7.04 | $525K | SEC |
| Apr 13, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | 74,268 | $7.21 | $535K | SEC |
| Apr 13, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Buy | 74,751 | $7.27 | $543K | SEC |
| Apr 9, 2026 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 29,319 | $6.53 | $191K | SEC |
| Apr 9, 2026 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 2,400 | $6.38 | $15K | SEC |
| Apr 9, 2026 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 32,523 | $6.29 | $205K | SEC |
| Apr 9, 2026 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 40,416 | $6.52 | $264K | SEC |
| Oct 10, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,500,000 | $1.00 | $1.5M | SEC |
| Oct 10, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 3,500,000 | $1.00 | $3.5M | SEC |
| Jun 7, 2024 | Kauffman Michael | Director | Sell | 5,900 | $1.43 | $8K | SEC |
| Jan 26, 2024 | OrbiMed Advisors Israel II Ltd | Director | Buy | 242,200 | $2.40 | $581K | SEC |
| Jan 26, 2024 | OrbiMed Advisors Israel II Ltd | Director | Buy | 1,041,700 | $2.40 | $2.5M | SEC |
| Jan 26, 2024 | GORDON CARL L | Director | Buy | 242,200 | $2.40 | $581K | SEC |
| Jan 26, 2024 | GORDON CARL L | Director | Buy | 1,041,700 | $2.40 | $2.5M | SEC |
| Jan 26, 2024 | GORDON CARL L | Director | Buy | 1,841,100 | $2.40 | $4.4M | SEC |
In the last 12 months Adicet Bio, Inc. insiders made open-market purchases worth about $1.6 million and sales worth about $675,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ACET was filed on 2026-04-13.
56 investment managers reported holding ACET in SEC Form 13F filings for Q2 2026.
No congressional trades in ACET were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).